Exudative, nonhealing scalp: a complication of systemic chemotherapy with capecitabine and bevacizumab.
Jeanette M
JM
Black
Kafele T
KT
Hodari
Nicole
N
Rogers
Patricia K
PK
Farris
Alan T
AT
Lewis
Erin E
EE
Boh
D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D000068258:Bevacizumab; D000069287:Capecitabine; D003110:Colonic Neoplasms / Q000188:drug therapy / Q000556:secondary; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology; D012536:Scalp Dermatoses / Q000139:chemically induced*; D012720:Severity of Illness Index; D012878:Skin Neoplasms / Q000473:pathology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003841:Deoxycytidine; D000068258:Bevacizumab; D000069287:Capecitabine; D005472:Fluorouracil